1254558-78-5 Usage
General Description
2-(2-bromo-1,3-thiazol-4-yl)acetonitrile is a chemical compound that is used in various industrial applications and research processes. It is a derivative of thiazole, which is a heterocyclic compound containing both sulfur and nitrogen atoms in its ring structure. The presence of the bromo group indicates that it contains a bromine atom, adding further versatility to its potential uses. Acetonitrile, also known as methyl cyanide, is a common solvent and reagent in organic synthesis, so the combination of these components suggests that 2-(2-bromo-1,3-thiazol-4-yl)acetonitrile likely has similar properties. This chemical compound may have uses in the development of pharmaceuticals, agrochemicals, or as an intermediate in the synthesis of other compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1254558-78-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,4,5,5 and 8 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1254558-78:
(9*1)+(8*2)+(7*5)+(6*4)+(5*5)+(4*5)+(3*8)+(2*7)+(1*8)=175
175 % 10 = 5
So 1254558-78-5 is a valid CAS Registry Number.
1254558-78-5Relevant articles and documents
Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides
Russell, Stephanie,Rahmani, Rapha?l,Jones, Amy J.,Newson, Harriet L.,Neilde, Kevin,Cotillo, Ignacio,Rahmani Khajouei, Marzieh,Ferrins, Lori,Qureishi, Sana,Nguyen, Nghi,Martinez-Martinez, Maria S.,Weaver, Donald F.,Kaiser, Marcel,Riley, Jennifer,Thomas, John,De Rycker, Manu,Read, Kevin D.,Flematti, Gavin R.,Ryan, Eileen,Tanghe, Scott,Rodriguez, Ana,Charman, Susan A.,Kessler, Albane,Avery, Vicky M.,Baell, Jonathan B.,Piggott, Matthew J.
, p. 9686 - 9720 (2016/11/19)
The parasitic trypanosomes Trypanosoma brucei and T. cruzi are responsible for significant human suffering in the form of human African trypanosomiasis (HAT) and Chagas disease. Drugs currently available to treat these neglected diseases leave much to be